Breaking news: Novo Nordisk has appointed Maziar Mike Doustdar as chief executive and president of the group as it slashed its sales and profit forecasts for the year amid stiff US competition for its blockbuster weight-loss drugs. on.ft.com/4mlLsbM (Financial Times)